XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.20.2

Supplemental Cash Flow Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2020
Supplemental Cash Flow Information [Abstract] |
Schedule of Supplemental Cash Flow Information | The following table summarizes supplemental cash flows for the six months ended September 30, 2020 and 2019:
|  | 2020 |  |  | 2019 |
Cash paid for interest |  | $ | 101,000 |  |  | $ | 128,000 |
Non-cash investing and financing activities: |  |  |  |  |  |  |  |
Impact of adoption of lease accounting standards |  | $ | - |  |  | $ | 1,616,000 |
Gain from change in fair value of interest rate swap derivatives |  | $ | - |  |  | $ | 7,000 |
Common stock issued upon conversion of convertible note |  | $ | - |  |  | $ | 500,000 |
Equity issued to purchase intangible assets |  | $ | - |  |  | $ | 145,000 |
Common Shares issued for marketing services |  | $ | 210,000 |  |  | $ | - |
Common Shares issued for Impact BioMedical |  | $ | 3,132,000 |  |  | $ | - |
Series A Preferred Shares issued for Impact BioMedical |  | $ | 35,187,000 |  |  | $ | - |
Long-lived assets acquired through settlement of notes receivable |  | $ | 838,000 |  |  | $ | - |

X
- Definition Tabular disclosure of supplemental cash flow information for the periods presented. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SupplementalCashFlowInformationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration